Market Tracker

09/27 5:16pm ET

Depomed Inc (NASDAQ:DEPO)

24.40
Delayed Data
As of 3:59pm ET
 +0.20 / +0.83%
Today’s Change
12.25
Today|||52-Week Range
25.50
+34.58%
Year-to-Date
How Much Could DepoMed Fetch in a Deal?
Sep 22 / MotleyFool.com - Paid Partner Content
Why DepoMed's Shares Are Jumping 12% Today
Sep 16 / MotleyFool.com - Paid Partner Content
Why Avis Budget Group, Depomed, and Community Health Systems Jumped Today
Sep 16 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close24.20
Today’s open24.19
Day’s range23.80 - 24.54
Volume2,005,615
Average volume (3 months)1,255,774
Market cap$1.5B
Dividend yield--
Data as of 3:59pm ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)-161.46%
Earnings growth (this year)+72.28%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)-12.20%
P/E ratioNM
Price/Sales3.18
Price/Book4.67

Competitors

 Today’s
change
Today’s
% change
CBMCambrex Corp-0.60-1.30%
HCMHutchison China Medi...-0.11-0.90%
AXONAxovant Sciences Ltd-0.12-0.82%
CLVSClovis Oncology Inc+0.62+1.68%
Data as of 4:02pm ET, 09/27/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$0.37
Annual revenue (last year)$342.7M
Annual profit (last year)-$75.7M
Net profit margin-22.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
Chief Financial Officer &
Senior Vice President
August J. Moretti
Corporate headquarters
Newark, California

Forecasts